METASTATIC COLORECTAL CANCER
Clinical trials for METASTATIC COLORECTAL CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC COLORECTAL CANCER trials appear
Sign up with your email to follow new studies for METASTATIC COLORECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Terminated trial tested unusual drug mix for tough liver cancers
Disease control TerminatedThis study tested whether combining three existing drugs—nivolumab (an immunotherapy), tadalafil (a blood pressure/erectile dysfunction drug), and oral vancomycin (an antibiotic)—could shrink advanced liver cancers. It was for adults whose liver cancer (either starting in the liv…
Matched conditions: METASTATIC COLORECTAL CANCER
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Two-Pronged attack tested for Tough-to-Treat colon cancer
Disease control TerminatedThis study tested a combination of two drugs, VB-111 and nivolumab, for people with advanced colorectal cancer that had spread to the liver and had stopped responding to standard chemotherapy. The main goals were to check if the treatment was safe and to see if it could cause tum…
Matched conditions: METASTATIC COLORECTAL CANCER
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Blood test trial seeks faster answers for tough cancers
Knowledge-focused TerminatedThis study aimed to see if simple blood tests could help doctors make better treatment decisions for people with advanced pancreatic, bile duct, or colorectal cancers. Researchers wanted to check if these 'liquid biopsies' could identify the right patients for specific drugs or t…
Matched conditions: METASTATIC COLORECTAL CANCER
Sponsor: Oslo University Hospital • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:56 UTC